$ESRX Express Scripts Holding Co. Insider Trading Week 10/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Express Scripts Holding Co..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Express Scripts Holding Co. in week 10/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Option Exercise | A | 67.62 | 271,714 | 18,373,301 | 271,714 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 56,689 | 0 | 209,863 | 153.2 K to 209.9 K (+37.01 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Payment of Exercise | F | 67.62 | 17,613 | 1,190,991 | 153,174 | 170.8 K to 153.2 K (-10.31 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 36,730 | 0 | 170,787 | 134.1 K to 170.8 K (+27.40 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Option Exercise | A | 67.62 | 50,798 | 3,434,961 | 50,798 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Grant | A | 0.00 | 10,598 | 0 | 57,760 | 47.2 K to 57.8 K (+22.47 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 67.62 | 7,123 | 481,657 | 47,162 | 54.3 K to 47.2 K (-13.12 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Grant | A | 0.00 | 14,854 | 0 | 54,285 | 39.4 K to 54.3 K (+37.67 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | A | 67.62 | 30,715 | 2,076,948 | 30,715 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 6,408 | 0 | 40,503 | 34.1 K to 40.5 K (+18.79 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 67.62 | 4,160 | 281,299 | 34,095 | 38.3 K to 34.1 K (-10.87 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 9,361 | 0 | 38,255 | 28.9 K to 38.3 K (+32.40 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | SLUSSER ERIC | Exec. VP & CFO | Option Exercise | A | 67.62 | 64,975 | 4,393,610 | 64,975 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | SLUSSER ERIC | Exec. VP & CFO | Grant | A | 0.00 | 13,556 | 0 | 37,218 | 23.7 K to 37.2 K (+57.29 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Sample Neal J. | Sr. VP & Ch. Inform ... | Option Exercise | A | 67.62 | 47,254 | 3,195,315 | 47,254 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Sample Neal J. | Sr. VP & Ch. Inform ... | Grant | A | 0.00 | 9,859 | 0 | 28,614 | 18.8 K to 28.6 K (+52.57 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Option Exercise | A | 67.62 | 51,980 | 3,514,888 | 51,980 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Grant | A | 0.00 | 10,844 | 0 | 36,649 | 25.8 K to 36.6 K (+42.02 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Payment of Exercise | F | 67.62 | 5,207 | 352,097 | 25,805 | 31 K to 25.8 K (-16.79 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Grant | A | 0.00 | 11,163 | 0 | 31,012 | 19.8 K to 31 K (+56.24 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 67.62 | 36,263 | 2,452,104 | 953,343 | 989.6 K to 953.3 K (-3.66 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Grant | A | 0.00 | 75,625 | 0 | 989,606 | 914 K to 989.6 K (+8.27 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Option Exercise | A | 67.62 | 51,980 | 3,514,888 | 51,980 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Grant | A | 0.00 | 10,844 | 0 | 19,779 | 8.9 K to 19.8 K (+121.37 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | A | 67.62 | 41,347 | 2,795,884 | 41,347 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 8,626 | 0 | 46,033 | 37.4 K to 46 K (+23.06 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 67.62 | 3,420 | 231,260 | 37,407 | 40.8 K to 37.4 K (-8.38 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 7,921 | 0 | 40,827 | 32.9 K to 40.8 K (+24.07 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | McGinnis Christopher A | VP, Controller & Ch ... | Grant | A | 0.00 | 3,947 | 0 | 6,675 | 2.7 K to 6.7 K (+144.68 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Option Exercise | A | 67.62 | 64,975 | 4,393,610 | 64,975 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Grant | A | 0.00 | 13,556 | 0 | 77,296 | 63.7 K to 77.3 K (+21.27 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Payment of Exercise | F | 67.62 | 5,698 | 385,299 | 63,740 | 69.4 K to 63.7 K (-8.21 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Grant | A | 0.00 | 11,882 | 0 | 69,438 | 57.6 K to 69.4 K (+20.64 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | A | 67.62 | 23,627 | 1,597,658 | 23,627 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Grant | A | 0.00 | 4,929 | 0 | 12,208 | 7.3 K to 12.2 K (+67.72 %) |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Akins Martin P. | Senior VP & General ... | Option Exercise | A | 67.62 | 47,254 | 3,195,315 | 47,254 | |
| Mar 10 2017 | ESRX | Express Scripts Ho ... | Akins Martin P. | Senior VP & General ... | Grant | A | 0.00 | 9,859 | 0 | 28,310 | 18.5 K to 28.3 K (+53.43 %) |
| Mar 07 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Option Exercise | M | 49.50 | 10,742 | 531,675 | 0 | |
| Mar 07 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Payment of Exercise | F | 71.58 | 8,871 | 634,986 | 57,556 | 66.4 K to 57.6 K (-13.35 %) |
| Mar 07 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Buy | M | 49.50 | 10,742 | 531,675 | 66,427 | 55.7 K to 66.4 K (+19.29 %) |
| Mar 07 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Option Exercise | M | 49.50 | 174,386 | 8,631,235 | 0 | |
| Mar 07 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 71.58 | 146,381 | 10,477,952 | 913,981 | 1.1 M to 914 K (-13.80 %) |
| Mar 07 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Buy | M | 49.50 | 174,386 | 8,631,235 | 1,060,362 | 886 K to 1.1 M (+19.68 %) |